These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 34388112)
21. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
22. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles. Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760 [TBL] [Abstract][Full Text] [Related]
23. A novel miRNA-based signature as predictive tool of survival outcome of colorectal cancer patients. Zhao B; Wang W; Ye H; Wang J; Meng K; Yang T Chem Biol Drug Des; 2023 Nov; 102(5):1024-1033. PubMed ID: 37532274 [TBL] [Abstract][Full Text] [Related]
24. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations. Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896 [TBL] [Abstract][Full Text] [Related]
25. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p. Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer. Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988 [TBL] [Abstract][Full Text] [Related]
27. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
28. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer. Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122 [TBL] [Abstract][Full Text] [Related]
29. Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis. Sharma B; Randhawa V; Vaiphei K; Gupta V; Dahiya D; Agnihotri N J Steroid Biochem Mol Biol; 2021 Apr; 208():105822. PubMed ID: 33465419 [TBL] [Abstract][Full Text] [Related]
30. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
31. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. Wang K; Chen M; Wu W World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412 [TBL] [Abstract][Full Text] [Related]
32. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
33. SOX9, miR-495, miR-590-3p, and miR-320d were identified as chemoradiotherapy-sensitive genes and miRNAs in colorectal cancer patients based on a microarray dataset. Du B; Wang T; Yang X; Wang J; Shi X; Wang X; Wu D; Feng L; Chen L; Zhang W Neoplasma; 2019 Jan; 66(1):8-19. PubMed ID: 30509082 [TBL] [Abstract][Full Text] [Related]
34. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer. Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020 [TBL] [Abstract][Full Text] [Related]
35. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration. Ye Z; Jiang Y; Wu J Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898 [TBL] [Abstract][Full Text] [Related]
36. Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer. Feng H; Xu M; Zhang Y; Han B; Wang J; Sun P Clin Lab; 2018 May; 64(5):797-804. PubMed ID: 29739047 [TBL] [Abstract][Full Text] [Related]
37. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC. Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396 [TBL] [Abstract][Full Text] [Related]
38. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551 [TBL] [Abstract][Full Text] [Related]
39. Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression. Li J; Liang L; Xiu L; Zeng J; Zhu Y; An J; Wu L Ann Transl Med; 2022 Jan; 10(2):125. PubMed ID: 35282101 [TBL] [Abstract][Full Text] [Related]
40. Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma. Li G; Yang H; Cheng Y; Zhao X; Li X; Jiang R Cancer Cell Int; 2020; 20():317. PubMed ID: 32694939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]